Health
Pfizer, BioNTech start testing COVID-19 vaccine in pregnant women – Reuters
Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy…
CHICAGO, Feb 18 (Reuters) – Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women, the companies said on Thursday.
Pregnant women are at higher risk of developing severe COVID-19, and many public health officials have recommended some women in high-risk professions take coronavirus vaccines even without proof they are safe for them.
Last week, the U.S. National Institutes of…
-
General23 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General8 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News24 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’